CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 287 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02147184
NCT02147184N/ACompleted

Serotonin Reuptake Inhibitors and Bone Mineralization in Adolescents

Chadi A. Calarge·observational·Posted May 26, 2014·Updated Jun 28, 2023

In Brief

An observational study for The Skeletal Effects of SSRIs. Completed, enrolled 287 participants across 1 site.

Detailed Summary

Building on findings from animal studies, pediatric clinical trials, epidemiologic research in adults, and on preliminary findings from the investigators' laboratory in children and adolescents, this project aims to investigate whether selective serotonin reuptake inhibitors (SSRIs), a group of widely-used psychotropics, are associated with impaired bone mineralization in youths. Establishing such an association is a first step in a process that would eventually involve developing preventative interventions. Identifying genetic factors that place certain youths at higher risks for this side effect would ultimately allow clinicians to tailor treatment to the needs and vulnerabilities of each youth, moving the field closer towards individualized medicine.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMay 26, 2014
Enrollment StartSep 1, 2010
Primary CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 12.1 years ago